Clinical Trials Directory

Explore 21,535 clinical trials worldwide

Showing 15351-15400 of 21,535 trials

Active filters:Status: Active, not recruiting

Clinical Trials (21,535)

NCT05267496
Oscillating Positive Expiratory Pressure Therapy for Patients With Thoracic Neoplasms Undergoing Chest Surgery
NAActive, not recruiting
72 participants
Started: Aug 13, 2019 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT04047706
Nivolumab, BMS-986205, and Radiation Therapy With or Without Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma
PHASE1Active, not recruiting
18 participants
Started: Aug 13, 2019 · Completed: Jun 1, 2027
1 condition2 sponsors1 location
NCT04009499
A Study to Assess the Long-term Safety, Tolerability, and Efficacy of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis
PHASE3Active, not recruiting
1,131 participants
Started: Aug 13, 2019 · Completed: May 25, 2026
1 condition1 sponsor138 locations
NCT04071457
S1803, Lenalidomide +/- Daratumumab/rHuPh20 as Post-ASCT Maintenance for MM w/MRD to Direct Therapy Duration
PHASE3Active, not recruiting
1,100 participants
Started: Aug 13, 2019 · Completed: Jul 1, 2040
1 condition3 sponsors842 locations
NCT04734158
CORNEAL EPITHELIAL MAPPING IN DIABETICS
N/AActive, not recruiting
153 participants
Started: Aug 12, 2019 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04036435
Long-Term Study That Measures the Safety and Efficacy of Deucravacitinib (BMS-986165) in Participants With Psoriasis
PHASE3Active, not recruiting
1,466 participants
Started: Aug 12, 2019 · Completed: Jul 26, 2026
1 condition1 sponsor302 locations
NCT04035811
Prospective Clinical Assessment Study in Children With Achondroplasia (ACH)
N/AActive, not recruiting
271 participants
Started: Aug 12, 2019 · Completed: Jun 30, 2026
1 condition1 sponsor32 locations
NCT04035005
A Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
PHASE3Active, not recruiting
1,013 participants
Started: Aug 12, 2019 · Completed: Jan 19, 2028
1 condition1 sponsor159 locations
NCT03975634
Transcutaneous Spinal Stimulation: Safety and Feasibility for Trunk Control in Children With Spinal Cord Injury
NAActive, not recruiting
9 participants
Started: Aug 12, 2019 · Completed: Jun 30, 2025
1 condition2 sponsors1 location
NCT05773222
Efficacy and Safety of Apixaban in Korean Frail Atrial Fibrillation Patient
N/AActive, not recruiting
2,500 participants
Started: Aug 12, 2019 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT03735420
Xanthohumol Metabolism and Signature
PHASE1Active, not recruiting
30 participants
Started: Aug 12, 2019 · Completed: Dec 31, 2024
1 condition3 sponsors1 location
NCT04196452
A Retrospective Observational Study on the Long-term Effects of Ipilimumab-treated Pediatric Participants in the Dutch Melanoma Treatment Registry (DMTR)
N/AActive, not recruiting
10 participants
Started: Aug 12, 2019 · Completed: Jun 30, 2034
1 condition1 sponsor0 locations
NCT03706482
Boost Brittle Bones Before Birth
PHASE1/PHASE2Active, not recruiting
18 participants
Started: Aug 12, 2019 · Completed: Apr 30, 2030
1 condition8 sponsors1 location
NCT03742193
Pulmonary Resectable Metastases of Osteosarcoma With Anti-angiogenics and CHemotherapy
PHASE2Active, not recruiting
43 participants
Started: Aug 11, 2019 · Completed: Dec 30, 2023
3 conditions1 sponsor1 location
NCT04037358
RAdium-223 and SABR Versus SABR for Oligometastatic Prostate Cancers
PHASE2Active, not recruiting
64 participants
Started: Aug 9, 2019 · Completed: Dec 31, 2028
1 condition3 sponsors1 location
NCT04352816
Magnetocardiography (MCG) Parameters in the Prediction of Future ICD Therapy
NAActive, not recruiting
103 participants
Started: Aug 9, 2019 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT04083963
Phase 2 Trial of Neoadjuvant Weekly Carboplatin Plus Paclitaxel in Triple Negative Breast Cancer
PHASE2Active, not recruiting
13 participants
Started: Aug 9, 2019 · Completed: Sep 27, 2026
1 condition1 sponsor1 location
NCT04001829
Taxane and Taxane-Induced Peripheral Neuropathy in African American Patients With Stage I-III Breast Cancer
PHASE2Active, not recruiting
249 participants
Started: Aug 9, 2019 · Completed: Mar 31, 2027
21 conditions2 sponsors485 locations
NCT03584152
Postoperative Pain Management in Rhinoplasty
PHASE2Active, not recruiting
130 participants
Started: Aug 9, 2019 · Completed: Sep 30, 2025
1 condition1 sponsor1 location
NCT04578678
Can Subthalamic Stimulation Using Directional Electrodes Improve Postoperative Management in Parkinson's Disease
N/AActive, not recruiting
105 participants
Started: Aug 9, 2019 · Completed: Mar 31, 2026
2 conditions2 sponsors4 locations
NCT06400251
Testing Ipatasertib as Potentially Targeted Treatment in Cancers With AKT Genetic Changes (MATCH - Subprotocol Z1K)
PHASE2Active, not recruiting
35 participants
Started: Aug 8, 2019 · Completed: Dec 31, 2025
5 conditions1 sponsor1 location
NCT04106856
Losartan and Hypofractionated Rx After Chemo for Tx of Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer (SHAPER)
PHASE1Active, not recruiting
22 participants
Started: Aug 8, 2019 · Completed: Aug 8, 2026
7 conditions2 sponsors1 location
NCT03873259
Intraoperative Assessment of of Burst Wave Lithotripsy (BWL)
NAActive, not recruiting
40 participants
Started: Aug 8, 2019 · Completed: Apr 30, 2026
2 conditions3 sponsors2 locations
NCT04040634
Optimal Blood Pressure for the prevenTIon of Major vAscuLar Events in Patients With DIABETES Mellitus (OPTIMAL-DIABETES)
NAActive, not recruiting
9,479 participants
Started: Aug 8, 2019 · Completed: Dec 31, 2025
4 conditions2 sponsors32 locations
NCT03869905
Aquamin® as an Adjuvant Intervention for Ulcerative Colitis
PHASE2Active, not recruiting
40 participants
Started: Aug 8, 2019 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT03622788
Cytokine-Treated Veto Cells in Treating Patients With Hematologic Malignancies Following Stem Cell Transplant
PHASE1/PHASE2Active, not recruiting
16 participants
Started: Aug 8, 2019 · Completed: Dec 1, 2025
13 conditions1 sponsor1 location
NCT03779334
A Study of Risdiplam in Infants With Genetically Diagnosed and Presymptomatic Spinal Muscular Atrophy
PHASE2Active, not recruiting
26 participants
Started: Aug 7, 2019 · Completed: Mar 31, 2027
1 condition1 sponsor7 locations
NCT03375762
REMOTE Ischemic Perconditioning Among Acute Ischemic Stroke Patients ( REMOTE-CAT)
NAActive, not recruiting
572 participants
Started: Aug 7, 2019 · Completed: Apr 1, 2024
1 condition2 sponsors1 location
NCT04430725
Microwave Ablation or Wedge Resection for the Treatment of Lung, Sarcoma and Colorectal Lesions, ALLUME Study
N/AActive, not recruiting
74 participants
Started: Aug 7, 2019 · Completed: Jan 1, 2026
22 conditions2 sponsors1 location
NCT04030455
Cisplatin, Docetaxel, and Pembrolizumab in Treating Patients With Stage II-III Laryngeal Cancer
PHASE2Active, not recruiting
27 participants
Started: Aug 7, 2019 · Completed: Nov 1, 2025
3 conditions2 sponsors1 location
NCT04058652
Use of Transcutaneous Electrical Nerve Stimulation for Reducing Biologic Injection Site Pain(TENS Study)
NAActive, not recruiting
20 participants
Started: Aug 7, 2019 · Completed: Jul 31, 2026
1 condition1 sponsor1 location
NCT03893487
Fimepinostat in Treating Brain Tumors in Children and Young Adults
EARLY_PHASE1Active, not recruiting
30 participants
Started: Aug 7, 2019 · Completed: Aug 31, 2027
5 conditions4 sponsors19 locations
NCT03884712
Using CalmiGo to Manage Anxiety and Panic Attack Symptoms in the Emergency Department
NAActive, not recruiting
35 participants
Started: Aug 7, 2019 · Completed: Oct 1, 2025
2 conditions2 sponsors1 location
NCT04304066
Research for the Molecular Imaging of the PD-L1 Targeting Tracer
NAActive, not recruiting
50 participants
Started: Aug 6, 2019 · Completed: Dec 31, 2024
2 conditions1 sponsor1 location
NCT04022343
Neoadjuvant Cabozantinib in Treating Patients With Locally Advanced Kidney Cancer
PHASE2Active, not recruiting
22 participants
Started: Aug 6, 2019 · Completed: Dec 9, 2025
3 conditions4 sponsors1 location
NCT04036409
Optimal Blood Pressure for the prevenTIon of Major vAscuLar Events in Stroke Patients
NAActive, not recruiting
4,369 participants
Started: Aug 5, 2019 · Completed: Dec 31, 2025
4 conditions2 sponsors30 locations
NCT04072952
A Phase 1/2 Trial of ARV-471 Alone and in Combination With Palbociclib (IBRANCE®) in Patients With ER+/HER2- Locally Advanced or Metastatic Breast Cancer
PHASE1/PHASE2Active, not recruiting
217 participants
Started: Aug 5, 2019 · Completed: Nov 30, 2025
1 condition2 sponsors16 locations
NCT04261543
The Effect of High Protein and Early Resistance Exercise Versus Usual Care in Critically Ill Patients
NAActive, not recruiting
120 participants
Started: Aug 5, 2019 · Completed: Dec 1, 2025
1 condition1 sponsor1 location
NCT04008030
A Study of Nivolumab, Nivolumab Plus Ipilimumab, or Investigator's Choice Chemotherapy for the Treatment of Participants With Deficient Mismatch Repair (dMMR)/Microsatellite Instability High (MSI-H) Metastatic Colorectal Cancer (mCRC)
PHASE3Active, not recruiting
839 participants
Started: Aug 5, 2019 · Completed: Jun 10, 2026
1 condition2 sponsors157 locations
NCT03770429
AZD6738 for Patients With Progressive MDS or CMML
PHASE1Active, not recruiting
52 participants
Started: Aug 5, 2019 · Completed: May 31, 2026
2 conditions2 sponsors4 locations
NCT04045379
LASER and Radiofrequency and Genitourinary Syndrome of Menopause
NAActive, not recruiting
195 participants
Started: Aug 5, 2019 · Completed: Aug 31, 2025
3 conditions2 sponsors1 location
NCT04051502
ICG-Enabled Mapping of Ovarian Sentinel Lymph Nodes: A Feasibility Study
EARLY_PHASE1Active, not recruiting
48 participants
Started: Aug 5, 2019 · Completed: Aug 31, 2026
2 conditions1 sponsor7 locations
NCT06183320
Can Flowable Bulk Fill Composites be Used in Proximal Area of Class II Restorations
NAActive, not recruiting
38 participants
Started: Aug 5, 2019 · Completed: Dec 30, 2026
1 condition1 sponsor1 location
NCT04012996
2-level Cervical Disc Replacement Comparing Prodisc C SK & Vivo to Mobi-C
NAActive, not recruiting
390 participants
Started: Aug 5, 2019 · Completed: May 13, 2028
1 condition1 sponsor30 locations
NCT03977129
Quantitative Flow Ratio (QFR) Guided Coronary Artery Bypass Grafting for Patients Undergoing Primary Valve Surgery With Concomitant Coronary Artery Disease
NAActive, not recruiting
792 participants
Started: Aug 4, 2019 · Completed: Aug 31, 2027
2 conditions2 sponsors12 locations
NCT03512405
Pembrolizumab and Blinatumomab in Treating Participants With Recurrent or Refractory Acute Lymphoblastic Leukemia
PHASE1/PHASE2Active, not recruiting
36 participants
Started: Aug 2, 2019 · Completed: Nov 11, 2025
4 conditions2 sponsors1 location
NCT04304248
Neoadjuvant Toripalimab Plus Platinum-based Doublet for Stage III Non-small Cell Lung Cancer
PHASE2Active, not recruiting
30 participants
Started: Aug 1, 2019 · Completed: Jul 30, 2026
1 condition1 sponsor1 location
NCT04011189
Pain Detection Through Automated Video Analysis
NAActive, not recruiting
370 participants
Started: Aug 1, 2019 · Completed: Dec 31, 2026
1 condition1 sponsor2 locations
NCT05515640
Dysautonomia and Systemic Interactions in Traumatic Brain Injury
N/AActive, not recruiting
24 participants
Started: Aug 1, 2019 · Completed: Jun 30, 2024
4 conditions4 sponsors1 location
NCT04198545
Ethnic Differences in Iron Absorption (FeGenes)
N/AActive, not recruiting
515 participants
Started: Aug 1, 2019 · Completed: Dec 31, 2025
2 conditions3 sponsors2 locations